Please provide your email address to receive an email when new articles are posted on . Patients with HF with reduced ejection fraction who were treated with a higher-dose beta-blocker and achieved a ...
CHICAGO –For nearly 40 years a class of drugs known as beta blockers have been proven to increase patients' survival prospects following a heart attack by decreasing the cardiac workload and oxygen ...
Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...
CHICAGO -- Initiating low-dose beta-blockers prior to discharge in heart failure patients hospitalized for worsening symptoms significantly improves the use of a drug that has been shown in previous ...
If there is a benefit to continuing beta-blockers beyond 1 year after acute MI, it might come with a lower dose. And for patients with LV dysfunction after STEMI, mineralocorticoid receptor ...
Please provide your email address to receive an email when new articles are posted on . Beta-blockers have traditionally been prescribed for chronic coronary syndromes. Recent guidelines have ...
The question of whether to alter beta-blocker therapy in patients with asthma has been reviewed extensively in the medical literature. [1,2,3,4,5] Cardioselective (beta-1) beta-blockers are ...
The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...
Beta-blockers may not reduce the risk of death or repeat heart attacks for patients with preserved heart function. Women may face higher risks from beta-blockers. Long-term use can cause side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results